Project Grant HT94252510208
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$707K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
The federal Project Grant award of $860,998.00 was issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from April 1, 2025 to March 31, 2028, supports neurophysiology research focused on understanding the epileptogenesis signals and biomarkers underlying post-traumatic epilepsy. This research, conducted by the Regents of the University of California, San Francisco (UCSF), aims to...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $1,072,500 Project Grant to Tufts University School of Medicine to support research on "Reducing Post-Traumatic Epilepsy by Blocking MIAT Signaling in Parvalbumin-Positive Inhibitory GABAergic Interneurons". The grant, awarded on April 1, 2025, with a completion date of March 31, 2028, aims to investigate innovative therapeutic approaches to...
This Project Grant award, valued at $999,975.63, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on investigating the molecular mechanisms of APOE4 vulnerability to Alzheimer's disease and identifying novel therapeutic targets. The award was granted to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research...
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The federal Project Grant award, titled "PROTEOMICS OF VASCULAR WALL AGING," is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $462,000.00 award was granted to the Albert Einstein College of Medicine in Bronx, NY, with a performance period from January 1, 2025 to December 31, 2026. This research grant supports advanced biomedical investigations focused on transforming healthcare for military service...
The Defense Health Agency awarded a $1.687 million Project Grant to the Icahn School of Medicine at Mount Sinai under the Military Medical Research and Development federal grant program (CFDA 12.420) for the period of May 1, 2023 to April 30, 2027. The grant will fund research investigating the role of medial amygdala circuits in mediating the effects of diet on post-traumatic behavioral and metabolic complications. Through basic, applied, and advanced biomedical research, this project aims to...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The Department of the Army Medical Command awarded a $488,086 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for the research project "BIOMARKER SIGNATURES OF POST-TRAUMATIC EPILEPTOGENESIS (PTEGENESIS) AND ITS TREATMENTS". The grant, with a performance period from May 1, 2025 to April 30, 2027, supports advanced biomedical research initiatives focused on...
The Department of the Army Medical Command awarded a $3,099,990 project grant to the Western Institute For Veterans Research under the Military Medical Research and Development program (CFDA 12.420). The grant will fund the MILITARY INJURIES - UNDERSTANDING POST-TRAUMATIC EPILEPSY (MINUTE): BIOINFORMATICS WITH BIG DATA TO EXAMINE MULTIMODAL PTE BIOMARKERS project from September 30, 2021 through September 29, 2025. The project aims to utilize bioinformatics and big data approaches to examine...